Featured
MoonLake’s Psoriatic Arthritis Drug Achieves Key Endpoints in Phase 3 Trial
MoonLake’s new treatment for psoriatic arthritis successfully met primary and secondary endpoints in its late-stage clinical trial, marking a major advance...